Saint Gobain: Board Of Directors Held On November

The Board of Directors of Compagnie de Saint-Gobain notes with satisfaction the progress made in the execution of the Group’s strategy as approved by the Board and presented by its Chief Executive Officer on July 27, 2007.

In this regard, the Board notes the recent successful acquisitions of Maxit and Norandex, as well as the sale of the Reinforcements and Composites business, and confirms that the projected divestment of the Packaging business will be implemented in timely fashion.

The Board of Directors of Compagnie de Saint-Gobain records the acquisition by investment firm Wendel of an interest in the Company’s capital, as well as the representations made by said firm in this respect when disclosing that it had crossed the 5%, 10% and 15% shareholding thresholds, in addition to the intentions stated by Wendel when exceeding the 10% shareholding threshold.

In compliance with the principle of equal treatment of shareholders and in accordance with stock market regulations, the Chief Executive Officer of Saint-Gobain will continue the appropriate dialogue with Wendel, in particular as regards the representation of the latter on the Board of Directors.

600450 Saint Gobain: Board Of Directors Held On November

See more news about:

Others also read

A bright future is ahead for glass, thanks to a serious focus on innovation, the environment, and sustainability, the industry’s annual prestige awards ceremony at the Millennium Gallery in Sheffield heard. (Thurs 22 November).
Let’s re-live the event highlights together.
Saint-Gobain has approved the most important operation planned in Europe, which will be carried out over the next two years.
The façade of the RAL building in Bonn unmistakeably showcases the identity of the client and user of the building.
Glassolutions’ Installation business has relaunched as Facades & Glazing Solutions UK Ltd (FGS) following its sale to private investment firm CoBe Capital.
SUPERCONTRYX - a lead glass should be an extremely important element of your medical facility’s X-ray protection strategy as it attenuates the effect of radiations significantly.

Add new comment